Summary
- Altria shares dipped unexpectedly last month.
- Income and value investors are buying shares again.
- Debt, Cronos and JUUL investments a worry for shareholders.
- Upside price target posted.
- Looking for a portfolio of ideas like this one? Members of DIY Value Investing get exclusive access to our model portfolio. Get started today »
Despite reaffirming its full-year guidance, investors dumped shares of Altria (MO) earlier last month. Selling pressure finally eased toward the end of September as investors bet the worst is behind the consumer defensive tobacco giant.

Investors may point to the 8.69% dividend yield as a cushion to offset the quarterly drop (-5.75%). Still, after a year-to-date loss of 26.54%, shareholders have a long way to go. Why is the tobacco firm heavily discounted, as UBS describes it, and will the rebound continue from here?
Altria Stock Underperforms
Investors punished Altria stock the most this year, compared to British Tobacco (BTI) and Phillip Morris (PM). The anticipation of regulatory restrictions against Altria’s JUUL investment adds more uncertainties that the other tobacco firms lack.

Chart courtesy of Stock Rover
On September 3, Altria said that JUUL significantly cut its global workforce and will consider exiting from poor-performing markets. It cited potentially leaving the EMEA (Europe, Middle East, and Africa) and APAC (Asia-Pacific) regions. Altria will assess the approach, which suggests that it will evaluate the long-term reduction of growth. It also warned that this may result in a revaluation of the value of its JUUL investment.
If that happens, Altria may take another non-cash writedown in its upcoming quarterly earnings report.

